Skip to main content

Published locations for FDA approves liso-cel as second-line therapy for LBCL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves liso-cel as second-line therapy for LBCL

User login

  • Reset your password
  • /content/fda-approves-liso-cel-second-line-therapy-lbcl
  • /hematologynews/article/255765/b-cell-lymphoma/fda-approves-liso-cel-second-line-therapy-lbcl
  • /fedprac/avaho/article/255765/b-cell-lymphoma/fda-approves-liso-cel-second-line-therapy-lbcl
  • /hematology-oncology/article/255765/b-cell-lymphoma/fda-approves-liso-cel-second-line-therapy-lbcl
  • /breast-cancer-icymi/article/255765/b-cell-lymphoma/fda-approves-liso-cel-second-line-therapy-lbcl
  • /b-cell-lymphoma-icymi/article/255765/b-cell-lymphoma/fda-approves-liso-cel-second-line-therapy-lbcl